Lyrica
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1000 Mylan Blvd, Canonsburg, Pennsylvani...Website
www.lyrica.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Lyrica
LYRICA® is currently approved for various indications in more than 130 countries and regions globally. In the U.S., LYRICA is indicated to treat fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain and pain after shingles in adults. In the U.S., LYRICA is approved as adjunctive therapy for the treatment of partial onset seizures in patients four years of age and older. LYRICA is also indicated to treat partial onset seizures in patients 4 years of age and older with epilepsy who take 1 or more other drugs for seizures.Explore more
Lyrica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lyrica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Lyrica is spiking on competitors!
Check if Lyrica has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Lyrica recently announced quarterly report
Website visits: Recent activity has been detected on your website
Lyrica, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Lyrica had a recent Job posting/layoffs
Product Launch: Get notified when Lyrica launches new products
Congratulate Masked Content for being promoted to Masked Content at Lyrica
Funding: Get notified immidiatlly once Lyrica has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Lyrica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lyrica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lyrica.
Lyrica Tech Stack
A closer look at the technologies used by Lyrica
Lyrica News & Media
Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin)
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for LYRICA®. This grant extends the period of U.S. market exclusivity for LYRICA by an additional six months, to June 30, 2019. LYRICA is currently approved in the U.S. for fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain and pain after shingles in adults. LYRICA is also approved as adjunctive therapy for the treatment
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lyrica
Sign Up For FreeTo access detailed company insights
LYRICA® is currently approved for various indications in more than 130 countries and regions globally. In the U.S., LYRICA is indicated to treat fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain and pain after shingles in adults. In the U.S., LYRICA is approved as adjunctive therapy for the treatment of partial onset seizures in pati... Read More
